Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 2,561,100 | 2,828,900 | 2,874,400 | 3,033,500 | 2,805,700 |
| Cost of Goods | 530,100 | 566,700 | 549,000 | 522,200 | 522,300 |
| Gross Profit | 2,031,000 | 2,262,200 | 2,325,400 | 2,511,300 | 2,283,400 |
| Operating Expenses | 1,280,200 | 1,573,300 | 1,522,400 | 1,463,800 | 1,284,700 |
| Operating Income | 750,900 | 689,601 | 803,000 | 1,047,700 | 999,000 |
| Interest Expense | 9,600 | 68,000 | 41,900 | 40,400 | 41,400 |
| Other Income | 65,400 | 74,499 | -45,800 | 53,800 | 76,800 |
| Pre-tax Income | 806,700 | 696,100 | 715,300 | 1,061,100 | 1,034,400 |
| Income Tax | 177,500 | 137,300 | 128,600 | 233,400 | 227,600 |
| Net Income Continuous | 629,200 | 558,800 | 586,700 | 827,700 | 806,800 |
| Net Income Extraordinary | N/A | N/A | -16,600 | N/A | N/A |
| Net Income | $629,200 | $575,400 | $570,100 | $827,700 | $806,800 |
| EPS Basic Total Ops | 0.58 | 0.53 | 0.53 | 0.77 | 0.75 |
| EPS Basic Continuous Ops | 0.58 | 0.51 | 0.55 | 0.77 | 0.75 |
| EPS Diluted Total Ops | 0.58 | 0.53 | 0.52 | 0.76 | 0.74 |
| EPS Diluted Continuous Ops | 0.58 | 0.51 | 0.54 | 0.76 | 0.74 |
| EBITDA(a) | $882,300 | $767,200 | $932,500 | $1,175,100 | $1,119,400 |